期刊
ACTA HAEMATOLOGICA
卷 112, 期 1-2, 页码 16-23出版社
KARGER
DOI: 10.1159/000077555
关键词
stem cell transplantation; chimerism; minimal residual disease; PCR; leukemia
类别
Analysis of donor chimerism has become a routine method for the documentation of engraftment after allogeneic hematopoietic stem cell transplantation (HSCT). In recent years several groups have also focused on the application of this technique for the detection of relapsing disease after allogeneic HSCT. This review addresses technical issues ( sensitivity, specificity) and discusses the advantages and limitations of methods currently used for chimerism analysis and their usefulness for the detection of MRD. In addition, the potential impact of novel procedures, e. g. subset chimerism or real-time PCR-based procedures, is discussed. Copyright (C) 2004 S. Karger AG, Basel.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据